Yes, when purchased strictly as "Research Use Only" for laboratory studies by qualified professionals aged 21 or older
Tirzepatide exhibited an affinity for GIPR equivalent to GIP binding, while its affinity for GLP-1R was approximately five times weaker compared to GLP-1. Frontiers in Endocrinology, 2024 This receptor selectivity profile means that impure preparations could disproportionately affect GLP-1R activation measurements, since the compounds GLP-1R activity operates at much higher concentrations (EC 934 pM vs
Khi GSH gim, c th mt i l chn chng li gc t do, dn n tn thng t bo, lo ha sm v suy gim chc nng m
September 16, 2025: New Possible Lawsuit Option for People Who Experienced Ozempic-Related Vision Loss More medical studies are finding that people who take semaglutide drugs like Ozempic are at an increased risk of a type of blindness caused by NAION (non-arteritic anterior ischemic optic neuropathy)
Contemporary Endocrinology, eds R
- March 5, 2026 - AM-PR In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care